{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T01:24:30Z","timestamp":1789781070720,"version":"4.0.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,3]],"date-time":"2020-03-03T00:00:00Z","timestamp":1583193600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,3]],"date-time":"2020-03-03T00:00:00Z","timestamp":1583193600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["U-01 58369"],"award-info":[{"award-number":["U-01 58369"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Canadian Donation and Transplant Research Program"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s10620-020-06166-w","type":"journal-article","created":{"date-parts":[[2020,3,3]],"date-time":"2020-03-03T07:02:50Z","timestamp":1583218970000},"page":"273-283","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Elevated Serum Liver-Type Fatty Acid Binding Protein Levels in Non-acetaminophen Acute Liver Failure Patients with Organ Dysfunction"],"prefix":"10.1007","volume":"66","author":[{"name":"For the US Acute Liver Failure Study Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1555-1089","authenticated-orcid":false,"given":"Constantine J.","family":"Karvellas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime L.","family":"Speiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9lanie","family":"Tremblay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William M.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher F.","family":"Rose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,3]]},"reference":[{"key":"6166_CR1","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/0140-6736(93)91736-6","volume":"342","author":"JG O\u2019Grady","year":"1993","unstructured":"O\u2019Grady JG, Williams R. Classification of acute liver failure. Lancet. 1993;342:743.","journal-title":"Lancet"},{"key":"6166_CR2","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.jhep.2010.03.023","volume":"53","author":"MJ McPhail","year":"2010","unstructured":"McPhail MJ, Wendon JA, Bernal W. Meta-analysis of performance of Kings\u2019s College Hospital Criteria in prediction of outcome in non-paracetamol-induced acute liver failure. J Hepatol. 2010;53:492\u2013499.","journal-title":"J Hepatol"},{"key":"6166_CR3","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/j.cgh.2016.03.046","volume":"14","author":"DG Koch","year":"2016","unstructured":"Koch DG, Tillman H, Durkalski V, Lee WM, Reuben A. Development of a model to predict transplant-free survival of patients with acute liver failure. Clin Gastroenterol Hepatol. 2016;14:1199\u20131206.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"6166_CR4","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1111\/j.1478-3231.2010.02243.x","volume":"30","author":"CJ Karvellas","year":"2010","unstructured":"Karvellas CJ, Safinia N, Auzinger G, et al. Medical and psychiatric outcomes for patients transplanted for acetaminophen-induced acute liver failure: a case-control study. Liver Int Off J Int Assoc Study Liver. 2010;30:826\u2013833.","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"key":"6166_CR5","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1002\/hep.21503","volume":"45","author":"LE Schmidt","year":"2007","unstructured":"Schmidt LE, Larsen FS. MELD score as a predictor of liver failure and death in patients with acetaminophen-induced liver injury. Hepatology. 2007;45:789\u2013796.","journal-title":"Hepatology"},{"key":"6166_CR6","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.cccn.2004.09.001","volume":"352","author":"M Pelsers","year":"2005","unstructured":"Pelsers M, Hermens W, Glatz JF. Fatty acid-binding proteins as plasma markers of tissue injury. Clin Chim Acta. 2005;352:15\u201335.","journal-title":"Clin Chim Acta"},{"key":"6166_CR7","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/hep.1840090104","volume":"9","author":"NM Bass","year":"1989","unstructured":"Bass NM, Barker ME, Manning JA, Jones AL, Ockner RK. Acinar heterogeneity of fatty acid binding protein expression in the livers of male, female and clofibrate-treated rats. Hepatology. 1989;9:12\u201321.","journal-title":"Hepatology"},{"key":"6166_CR8","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1002\/hep.28945","volume":"65","author":"CJ Karvellas","year":"2017","unstructured":"Karvellas CJ, Speiser JL, Tremblay M, Lee WM, Rose CF, Group USALFS. Elevated FABP1 serum levels are associated with poorer survival in acetaminophen-induced acute liver failure. Hepatology. 2017;65:938\u2013949.","journal-title":"Hepatology"},{"key":"6166_CR9","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","volume":"335","author":"E vonElm","year":"2007","unstructured":"vonElm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ. 2007;335:806\u2013808.","journal-title":"BMJ"},{"key":"6166_CR10","volume-title":"The hepatic coma syndromes and lactulose","year":"1979","unstructured":"Conn HO, Lieberthal MM, eds. The hepatic coma syndromes and lactulose. Philadelphia: Williams & Wilkins; 1979."},{"key":"6166_CR11","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1007\/BF01072921","volume":"23","author":"CE Atterbury","year":"1978","unstructured":"Atterbury CE, Maddrey WC, Conn HO. Neomycin-sorbitol and lactulose in the treatment of acute portal-systemic encephalopathy: a controlled, double-blind clinical trial. Am J Dig Dis. 1978;23:398\u2013406.","journal-title":"Am J Dig Dis"},{"key":"6166_CR12","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/0016-5085(89)90081-4","volume":"97","author":"JG O\u2019Grady","year":"1989","unstructured":"O\u2019Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology. 1989;97:439\u2013445.","journal-title":"Gastroenterology"},{"key":"6166_CR13","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1053\/jhep.2001.22172","volume":"33","author":"PS Kamath","year":"2001","unstructured":"Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001;33:464\u2013470.","journal-title":"Hepatology"},{"key":"6166_CR14","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1093\/aje\/kwh075","volume":"159","author":"X Li","year":"2004","unstructured":"Li X, Song X, Gray RH. Comparison of the missing-indicator method and conditional logistic regression in 1:m matched case-control studies with missing exposure values. Am J Epidemiol. 2004;159:603\u2013610.","journal-title":"Am J Epidemiol"},{"key":"6166_CR15","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.jhep.2010.11.024","volume":"55","author":"MA van den Broek","year":"2011","unstructured":"van den Broek MA, Bloemen JG, Dello SA, van de Poll MC, Olde Damink SW, Dejong CH. Randomized controlled trial analyzing the effect of 15 or 30\u00a0min intermittent Pringle maneuver on hepatocellular damage during liver surgery. J Hepatol. 2011;55:337\u2013345.","journal-title":"J Hepatol"},{"key":"6166_CR16","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1093\/clinchem\/48.11.2055","volume":"48","author":"MM Pelsers","year":"2002","unstructured":"Pelsers MM, Morovat A, Alexander GJ, Hermens WT, Trull AK, Glatz JF. Liver fatty acid-binding protein as a sensitive serum marker of acute hepatocellular damage in liver transplant recipients. Clin Chem. 2002;48:2055\u20132057.","journal-title":"Clin Chem"},{"key":"6166_CR17","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/BF00231388","volume":"98","author":"L Vergani","year":"1990","unstructured":"Vergani L, Fanin M, Martinuzzi A, et al. Liver fatty acid-binding protein in two cases of human lipid storage. Mol Cell Biochem. 1990;98:225\u2013230.","journal-title":"Mol Cell Biochem"},{"key":"6166_CR18","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.2353\/ajpath.2009.080644","volume":"174","author":"K Negishi","year":"2009","unstructured":"Negishi K, Noiri E, Doi K, et al. Monitoring of urinary L-type fatty acid-binding protein predicts histological severity of acute kidney injury. Am J Pathol. 2009;174:1154\u20131159.","journal-title":"Am J Pathol"},{"key":"6166_CR19","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/S0009-9120(03)00096-1","volume":"36","author":"MM Pelsers","year":"2003","unstructured":"Pelsers MM, Namiot Z, Kisielewski W, et al. Intestinal-type and liver-type fatty acid-binding protein in the intestine: tissue distribution and clinical utility. Clin Biochem. 2003;36:529\u2013535.","journal-title":"Clin Biochem"},{"key":"6166_CR20","first-page":"132","volume":"37","author":"M Mikus","year":"2016","unstructured":"Mikus M, Drobin K, Gry M, et al. Elevated levels of circulating CDH5 and FABP1 in association with human drug-induced liver injury. Liver Int Off J Int Assoc Study Liver. 2016;37:132\u2013140.","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"key":"6166_CR21","first-page":"1","volume":"1","author":"A Eguchi","year":"2019","unstructured":"Eguchi A, Hasegawa H, Iwasa M, et al. Serum liver-type fatty acid\u2013binding protein is a possible prognostic factor in human chronic liver diseases from chronic hepatitis to liver cirrhosis and hepatocellular carcinoma. Hepatol Commun. 2019;1:1\u201311.","journal-title":"Hepatol Commun"},{"key":"6166_CR22","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S0074-7696(08)61733-7","volume":"111","author":"NM Bass","year":"1988","unstructured":"Bass NM. The cellular fatty acid binding proteins: aspects of structure, regulation, and function. Int Rev Cytol. 1988;111:143\u2013184.","journal-title":"Int Rev Cytol"},{"key":"6166_CR23","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/BF01076480","volume":"123","author":"JH Veerkamp","year":"1993","unstructured":"Veerkamp JH, van Moerkerk HT. Fatty acid-binding protein and its relation to fatty acid oxidation. Mol Cell Biochem. 1993;123:101\u2013106.","journal-title":"Mol Cell Biochem"},{"key":"6166_CR24","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1111\/j.1432-0436.1985.tb00529.x","volume":"30","author":"RP Custer","year":"1985","unstructured":"Custer RP, Sorof S. Mitosis in hepatocytes is generally associated with elevated levels of the target polypeptide of a liver carcinogen. Differentiation. 1985;30:176\u2013181.","journal-title":"Differentiation"},{"key":"6166_CR25","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1023\/B:MCBI.0000038214.52184.82","volume":"262","author":"G Wang","year":"2004","unstructured":"Wang G, Chen QM, Minuk GY, Gong Y, Burczynski FJ. Enhanced expression of cytosolic fatty acid binding protein and fatty acid uptake during liver regeneration in rats. Mol Cell Biochem. 2004;262:41\u201349.","journal-title":"Mol Cell Biochem"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-020-06166-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-020-06166-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-020-06166-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,3]],"date-time":"2021-03-03T00:44:36Z","timestamp":1614732276000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-020-06166-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,3]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["6166"],"URL":"https:\/\/doi.org\/10.1007\/s10620-020-06166-w","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,3]]},"assertion":[{"value":"30 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"All authors have no personal or funding conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}